CastleArk Management »

Corcept Therapeutics Incorporated shares owned by CastleArk Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by CastleArk Management from 13F filings

Historical chart of CastleArk Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by CastleArk Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by CastleArk Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $228k 2.7k 83.11
2025-06-30 $2.7M 37k 73.40
2017-09-30 $3.5M 182k 19.30

More positions owned by CastleArk Management

Advisors Inner Circle Fd Ii Castleark Large (CARK)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Spdr Series Trust Portfolio Intrmd (SPIB)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Us Treas Bd Etf (GOVT)
Broadcom (AVGO)
Lam Research Corp Com New (LRCX)
Netflix (NFLX)
Arista Networks Com Shs (ANET)
Charles Schwab Corporation (SCHW)

View all positions for CastleArk Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated